These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 9773124)

  • 21. Recognized molecular mechanisms of heart failure: approaches to treatment.
    Ceconi C; Cargnoni A; Curello S; Ferrari R
    Rev Port Cardiol; 1998 Oct; 17 Suppl 2():II79-91. PubMed ID: 9835784
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differentiation in the effects of the angiotensin II receptor blocker class on autonomic function.
    Esler M
    J Hypertens Suppl; 2002 Jun; 20(5):S13-9. PubMed ID: 12184059
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Central sympathoexcitatory actions of angiotensin II: role of type 1 angiotensin II receptors.
    DiBona GF
    J Am Soc Nephrol; 1999 Jan; 10 Suppl 11():S90-4. PubMed ID: 9892146
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of the renin-angiotensin-aldosterone system in diabetes and its vascular complications.
    Cooper ME
    Am J Hypertens; 2004 Nov; 17(11 Pt 2):16S-20S; quiz A2-4. PubMed ID: 15539106
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neurohormonal activation in congestive heart failure and the role of vasopressin.
    Chatterjee K
    Am J Cardiol; 2005 May; 95(9A):8B-13B. PubMed ID: 15847852
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Relationship between the central renin-angiotensin system, stress and hypertension].
    Dumont EC; Drolet G
    Arch Mal Coeur Vaiss; 1999 Aug; 92(8):1111-3. PubMed ID: 10486675
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Volume-independent mechanisms of hypertension in hemodialysis patients: clinical implications.
    Blankestijn PJ; Ligtenberg G
    Semin Dial; 2004; 17(4):265-9. PubMed ID: 15250915
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The renin-angiotensin system and the sympathetic nervous system].
    Shigetomi S; Ueno S; Fukuchi S
    Nihon Rinsho; 1985 May; 43(5):889-93. PubMed ID: 3897646
    [No Abstract]   [Full Text] [Related]  

  • 29. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
    Weir MR
    Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Prospects for pharmacological effects on renin-angiotensin and sympathetic nervous systems in patients with arterial hypertension].
    Chikhladze NM
    Ter Arkh; 2000; 72(12):67-9. PubMed ID: 11201840
    [No Abstract]   [Full Text] [Related]  

  • 31. [Cardiovascular risk factors--an integrated sympathetic viewpoint].
    Bühler FR
    Schweiz Med Wochenschr; 1991 Dec; 121(49):1793-802. PubMed ID: 1754860
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Neuro-hormonal mechanisms in heart failure -- from physiopathology to treatment].
    Cerqueira-Gomes M; Polónia J; Brandão F; Ramalhão C; da Faria DB
    Rev Port Cardiol; 2001 May; 20 Suppl 5():V-99-122; discussion V-123-5. PubMed ID: 11515306
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pathogenesis of hypertension in renal failure: role of the sympathetic nervous system and renal afferents.
    Phillips JK
    Clin Exp Pharmacol Physiol; 2005; 32(5-6):415-8. PubMed ID: 15854151
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of nitric oxide in the regulation of cardiovascular autonomic control.
    Chowdhary S; Townend JN
    Clin Sci (Lond); 1999 Jul; 97(1):5-17. PubMed ID: 10369789
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Oral inhibitors of renin and their potential use as therapeutic agents in treating hypertension].
    Abassi Z; Armaly Z; Nakhoul F; Hoffman A
    Harefuah; 2008 Jun; 147(6):536-42, 573. PubMed ID: 18693632
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Angiotensin converting enzyme inhibition for cardiac hypertrophy in patients with end-stage renal disease: what is the evidence?
    Wang AY; Li PK; Lui SF; Sanderson JE
    Nephrology (Carlton); 2004 Aug; 9(4):190-7. PubMed ID: 15363049
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differential sympathetic and angiotensinergic responses in rats submitted to low- or high-salt diet.
    Carillo BA; Beutel A; Mirandola DA; Vidonho AF; Furukawa LN; Casarini D; Campos RR; Dolnikoff MS; Heimann JC; Bergamaschi CT
    Regul Pept; 2007 Apr; 140(1-2):5-11. PubMed ID: 17196676
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The renin-angiotensin system in the brain. Localization and functional significance.
    Paul M; Bader M; Steckelings UM; Voigtländer T; Ganten D
    Arzneimittelforschung; 1993 Feb; 43(2A):207-13. PubMed ID: 8498966
    [TBL] [Abstract][Full Text] [Related]  

  • 39. New approaches to the study of the cellular biology of the cardiovascular system.
    Re R; Rovigatti U
    Circulation; 1988 Jun; 77(6 Pt 2):I14-7. PubMed ID: 3286042
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Effects of changes in the sodium balance on plasma catecholamines and renin activity at rest and on their response to orthostatic stimulation in arterial hypertension].
    Morganti A; Pickering T; Lopez-Ovejero J; Laragh J
    Minerva Nefrol; 1981; 28(3):261-4. PubMed ID: 7036014
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.